Iovance Biotherapeutics, Inc. (IOVA) DCF Valuation

Iovance Biotherapeutics, Inc. (IOVA) Valation DCF

US | Healthcare | Biotechnology | NASDAQ
Iovance Biotherapeutics, Inc. (IOVA) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Iovance Biotherapeutics, Inc. (IOVA) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Vous cherchez à évaluer la valeur intrinsèque d'Iovance Biotherapeutics, Inc.? Notre calculatrice DCF (IOVA) intègre des données réelles avec des fonctionnalités de personnalisation complètes, vous permettant d'affiner vos prévisions et de faire des choix d'investissement plus éclairés.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 .0 .0 1.2 164.1 205.1 256.4 320.4 400.6 500.7
Revenue Growth, % 0 0 0 0 13698.99 25 25 25 25 25
EBITDA -250.9 -328.3 -374.8 -427.4 -395.3 41.0 51.3 64.1 80.1 100.1
EBITDA, % 100 100 100 -35948.86 -240.92 20 20 20 20 20
Depreciation 8.7 14.0 21.1 33.1 .0 164.1 205.1 256.4 320.4 400.6
Depreciation, % 100 100 100 2786.12 0 80 80 80 80 80
EBIT -259.6 -342.3 -395.9 -460.6 -395.3 41.0 51.3 64.1 80.1 100.1
EBIT, % 100 100 100 -38734.99 -240.92 20 20 20 20 20
Total Cash 629.4 596.0 471.8 279.9 323.8 205.1 256.4 320.4 400.6 500.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .2 69.3
Account Receivables, % 100 100 100 12.7 42.26
Inventories .0 .0 .0 10.4 51.5 177.0 221.2 276.5 345.6 432.0
Inventories, % 100 100 100 872.33 31.4 86.28 86.28 86.28 86.28 86.28
Accounts Payable 13.5 27.4 26.6 33.1 27.5 170.9 213.7 267.1 333.9 417.4
Accounts Payable, % 100 100 100 2785.79 16.77 83.35 83.35 83.35 83.35 83.35
Capital Expenditure -46.8 -37.6 -20.4 -22.3 -11.1 -43.8 -54.7 -68.4 -85.5 -106.9
Capital Expenditure, % 100 100 100 -1874.68 -6.75 -21.35 -21.35 -21.35 -21.35 -21.35
Tax Rate, % 0.75412 0.75412 0.75412 0.75412 0.75412 0.75412 0.75412 0.75412 0.75412 0.75412
EBITAT -257.2 -327.8 -389.9 -457.0 -392.3 40.3 50.4 63.0 78.8 98.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -281.8 -337.6 -390.0 -450.1 -519.3 102.4 162.9 203.6 254.5 318.1
WACC, % 8.22 8.21 8.22 8.22 8.22 8.22 8.22 8.22 8.22 8.22
PV UFCF
SUM PV UFCF 794.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 325
Terminal Value 5,219
Present Terminal Value 3,516
Enterprise Value 4,311
Net Debt -58
Equity Value 4,369
Diluted Shares Outstanding, MM 290
Equity Value Per Share 15.07

What You Will Receive

  • Pre-Filled Financial Model: Iovance Biotherapeutics' actual data provides an accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates allow you to view results instantly as you make adjustments.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, enabling repeated application for in-depth forecasts.

Key Features

  • 🔍 Real-Life IOVA Financials: Pre-filled historical and projected data for Iovance Biotherapeutics, Inc. (IOVA).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Iovance’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Iovance’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the pre-built Excel file containing Iovance Biotherapeutics, Inc. (IOVA) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC as needed.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various projections and analyze results immediately.
  • Make Decisions: Leverage the valuation outcomes to inform your investment approach.

Why Choose This Calculator for Iovance Biotherapeutics, Inc. (IOVA)?

  • User-Friendly Interface: Perfectly crafted for both novice and seasoned users.
  • Customizable Inputs: Adjust parameters easily to tailor your financial analysis.
  • Real-Time Feedback: Instantly observe changes in Iovance's valuation as you modify inputs.
  • Pre-Configured Data: Comes with Iovance’s actual financial statistics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Investors: Evaluate Iovance Biotherapeutics’ (IOVA) market potential before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
  • Startup Founders: Understand the valuation processes of innovative biotech firms like Iovance.
  • Consultants: Create comprehensive valuation reports for biotech clients.
  • Students and Educators: Utilize current data to learn and teach valuation strategies in the biotech sector.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Iovance Biotherapeutics historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Iovance Biotherapeutics, Inc. (IOVA).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

No products were found matching.